GeneDx Holdings Corp. Increase (Decrease) in Prepaid Expense and Other Assets
GeneDx Holdings Corp. (WGS) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$5.48 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2023-08-08
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-06-30 was -$1.24M.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for the quarter ending 2023-03-31 was -$4.23M.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-12-31 was -$5.98M.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for the quarter ending 2022-09-30 was -$2.24M, a 137.30% decline year-over-year.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for fiscal 2022 was -$11.13M, a 178.11% decline from fiscal 2021.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for fiscal 2021 was $14.25M.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for fiscal 2020 was -$2.50M, a 198.89% decline from fiscal 2019.
- GeneDx Holdings Corp. increase (decrease) in prepaid expense and other assets for fiscal 2019 was $2.53M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month |
|---|---|---|---|---|
| 2023-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$5.48M 10-Q · filed 2023-08-08 | -$11.45M derived: sum of 3 quarters · filed 2023-08-08 | -$13.70M derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | -$4.23M 10-Q · filed 2023-05-09 | -$10.21M derived: sum of 2 quarters · filed 2023-05-09 | -$12.45M derived: sum of 3 quarters · filed 2023-05-09 | -$13.77M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-12-31 | -$5.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$8.22M derived: sum of 2 quarters · filed 2023-03-16 | -$9.53M derived: sum of 3 quarters · filed 2023-08-08 | -$11.13M 10-K · filed 2023-03-16 |
| 2022-09-30 | -$2.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$3.56M derived: sum of 2 quarters · filed 2023-08-08 | -$5.15M 10-Q · filed 2022-11-14 | -$6.61M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-06-30 | -$1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$2.91M 10-Q · filed 2023-08-08 | -$4.37M derived: sum of 3 quarters · filed 2023-08-08 | $1.64M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$1.60M 10-Q · filed 2023-05-09 | -$3.06M derived: sum of 2 quarters · filed 2023-05-09 | $2.96M derived: sum of 3 quarters · filed 2023-05-09 | $6.33M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $4.55M derived: sum of 2 quarters · filed 2023-03-16 | $7.92M derived: sum of 3 quarters · filed 2023-03-16 | $14.25M 10-K · filed 2023-03-16 |
| 2021-09-30 | $6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $9.38M derived: sum of 2 quarters · filed 2022-11-14 | $15.71M 10-Q · filed 2022-11-14 | $13.73M derived: sum of 4 quarters · filed 2023-03-16 |
| 2021-06-30 | $3.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $9.70M 10-Q · filed 2022-08-15 | $7.71M derived: sum of 3 quarters · filed 2023-03-16 | |
| 2021-03-31 | $6.33M 10-Q · filed 2022-05-12 | $4.34M derived: sum of 2 quarters · filed 2023-03-16 | ||
| 2020-12-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$2.50M 10-K · filed 2023-03-16 | ||
| 2020-09-30 | -$516.00K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $2.53M 10-K · filed 2022-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |